NCT05879783 Optical Biopsy for Peritoneal Nodules in Colorectal Patients
| NCT ID | NCT05879783 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Nanfang Hospital, Southern Medical University |
| Condition | Colorectal Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 278 participants |
| Start Date | 2022-09-15 |
| Primary Completion | 2023-09-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 278 participants in total. It began in 2022-09-15 with a primary completion date of 2023-09-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
During surgery, peritoneal metastasis is typically confirmed pathologically through resection sample. However, this process can be time-consuming when utilizing intro-operative frozen section pathology. To address this issue, we propose utilizing confocal laser endomicroscopy to provide in situ, real-time, and in-vivo diagnosis of suspected peritoneal nodules as cancer metastasis during surgery.
Eligibility Criteria
Inclusion Criteria: 1. Age from over 18 to under 85 years 2. American Society of Anesthesiology (ASA) score class I,II,or III 3. Colorectal cancer 4. Patients who be about to undergo surgical treatment 5. Written informed consent Exclusion Criteria: 1. Pregnant or lactating women 2. Acute renal insufficiency or stage II to IV chronic renal insufficiency 3. Patients with severe liver damage 4. Asthma patients or patients with allergic constitution
Contact & Investigator
Jun Yan, M.D., Ph.D.
PRINCIPAL INVESTIGATOR
Nanfang Hospital, Southern Medical University
Frequently Asked Questions
Who can join the NCT05879783 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 85 Years, studying Colorectal Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05879783 currently recruiting?
Yes, NCT05879783 is actively recruiting participants. Contact the research team at yanjunfudan@163.com for enrollment information.
Where is the NCT05879783 trial being conducted?
This trial is being conducted at Guangzhou, China.
Who is sponsoring the NCT05879783 clinical trial?
NCT05879783 is sponsored by Nanfang Hospital, Southern Medical University. The principal investigator is Jun Yan, M.D., Ph.D. at Nanfang Hospital, Southern Medical University. The trial plans to enroll 278 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.